Efficacy of cyclosporine in a patient with lupus mesenteric vasculitis refractory to conventional immunosuppressive therapy

Abstract

Get full access to this article

View all access options for this article.

References

Liu

Zhu

Lai

, et al. Reports of three cases with the initial presentation of mesenteric vasculitis in children with system lupus erythematous. Clin Rheumatol 2018; 37: 277–283.

Mok

CC.

Calcineurin inhibitors in systemic lupus erythematosus.

Best Pract Res Clin Rheumatol 2017; 31: 429–438.

Al-Mogairen

SM.

Lupus protein-losing enteropathy (LUPLE): a systematic review.

Rheumatol Int 2011; 31: 995–1001.

Chang

Lai

Chen

Wang

Chou

and Tsai

CY.

Protein-losing enteropathy and premature ovarian failure in a young woman with systemic lupus erythematosus.

Lupus 2012; 21: 1237–1239.

Hill

Dwyer

and Power

DA.

Chronic intestinal pseudo-obstruction in systemic lupus erythematosus due to intestinal smooth muscle myopathy.

Lupus 2000; 9: 458–463.

Thorne

Alrubaiy

Akbari

Samuel

Sian

and Stephen

ER.

Colectomy rates in patients with ulcerative colitis following treatment with infliximab or ciclosporin: a systematic literature review.

Eur J Gastroenterol Hepatol 2016; 28: 369–382.

McCune

Golbus

Zeldes

Bohlke

Dunne

and Fox

DA.

Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. N Engl J Med 1988; 318: 1423–1431.

Dalmarco

Fröde

and Medeiros

YS.

Additional evidence of acute anti-inflammatory effects of cyclosporin A in a murine model of pleurisy. Transpl Immunol 2004; 12: 151–157.